The activity of a 0.1% amcinonide cream was compared with those of selected proprietary topical corticosteroid formulations of potencies differing according to the United Kingdom (U.K.) MIMS classification (very potent, potent and moderately potent) using a standard six hour vasoconstrictor assay with multiple reading times. Statistical analysis indicated that 0.1% amcinonide cream feU within the category of a very potent preparation. Three 0.1% amcinonide formulations (cream, combination cream and combination ointment, the last two containing anti-infective agents) were equipotent in the skin-blanching test
Ethanolic solutions of 8 new, topically active, anti-inflammatory steroids and 1 standard (betametha...
The bioavailabilities of three locally manufactured proprietary betamethasone- 17-valerate containin...
Currently, clinical trials in patients are required by most regulatory authorities for the assessmen...
Numerous experiments in recent years have indicated differences in the bioavailability of corticoste...
Two possible variables of the McKenzie/Stoughton blanching assay, namely amount applied to the test ...
The potencies of topical corticosteroid products have mainly been classified using clinical data but...
The human skin-blanching (or vasoconstrictor) assay has evolved from initial observations that corti...
The human skin blanching assay remains in widespread use as a reliable, qualitative, comparative ind...
Introduction: We report on a double-blind, vehicle-controlled, single-center confirmatory study with...
Bioavailability concerns for topical dermatological products are complex and it is especially diffic...
The effect of concentration and occlusion time on the ability of Betnovate ® cream (betamethasone 17...
The human skin blanching (vasoconstriction) assay for the assessment of topical corticosteroids has ...
It seems to us, and others (Burdick, 1974), that multiple reading times are essential to produce the...
From introduction: Topical corticosteroids are still the most widely used drugs in the treatment of ...
The blanching activities of Betnovate and Celestoderm-V lotions (betamethasone-17-valerate, 0,1%) an...
Ethanolic solutions of 8 new, topically active, anti-inflammatory steroids and 1 standard (betametha...
The bioavailabilities of three locally manufactured proprietary betamethasone- 17-valerate containin...
Currently, clinical trials in patients are required by most regulatory authorities for the assessmen...
Numerous experiments in recent years have indicated differences in the bioavailability of corticoste...
Two possible variables of the McKenzie/Stoughton blanching assay, namely amount applied to the test ...
The potencies of topical corticosteroid products have mainly been classified using clinical data but...
The human skin-blanching (or vasoconstrictor) assay has evolved from initial observations that corti...
The human skin blanching assay remains in widespread use as a reliable, qualitative, comparative ind...
Introduction: We report on a double-blind, vehicle-controlled, single-center confirmatory study with...
Bioavailability concerns for topical dermatological products are complex and it is especially diffic...
The effect of concentration and occlusion time on the ability of Betnovate ® cream (betamethasone 17...
The human skin blanching (vasoconstriction) assay for the assessment of topical corticosteroids has ...
It seems to us, and others (Burdick, 1974), that multiple reading times are essential to produce the...
From introduction: Topical corticosteroids are still the most widely used drugs in the treatment of ...
The blanching activities of Betnovate and Celestoderm-V lotions (betamethasone-17-valerate, 0,1%) an...
Ethanolic solutions of 8 new, topically active, anti-inflammatory steroids and 1 standard (betametha...
The bioavailabilities of three locally manufactured proprietary betamethasone- 17-valerate containin...
Currently, clinical trials in patients are required by most regulatory authorities for the assessmen...